Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults.
Breidenbach M, Bader P, Attarbaschi A, Rossig C, Meisel R, Metzler M, Subklewe M, Mueller F, Schlegel PG, Teichert von Lüttichau I, Bourquin JP, Escherich G, Cario G, Lang P, Coffey R, von Stackelberg A, Willier S, Strahm B, Peters C, Feuchtinger T.
Breidenbach M, et al. Among authors: mueller f.
J Hematol Oncol. 2025 Jan 17;18(1):8. doi: 10.1186/s13045-024-01659-x.
J Hematol Oncol. 2025.
PMID: 39825416
Free PMC article.